Stocks started this year with heft gains, edged back last week, and now are rising again. The big tech giants led the moves...
There is still no cure for COVID-19, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
Rashes and lesions are a potentially useful way of spotting COVID-19 patients who are otherwise asymptomatic.
Perhaps we should rethink how we monitor pregnant women who have COVID.
Regeneron Pharmaceuticals released positive Phase 2 trial results, which showed that a single dose of of its investigational antibody cocktail therapy prevented early asthma reactions in cat-allergic...
Friday the FDA Advisory Panel voted unanimously (22-0) to endorse the (one-shot, no mRNA) J&J.
Eli Lilly said the U.S. government agreed to buy at least 100,000 doses of the company's newly authorized COVID-19 dual antibody cocktail for $210 million, with...
Genes that control blood type and are involved in inflammation have been associated with more severe disease.
COVID-19 has highlighted the need to address the different cultures of academia and policymaking.
Credit: Image by RAEng_Publications from Pixabay, CC0 The rapid onset of the COVID-19 pandemic, which is caused by the SARS-CoV-2 virus, has meant that many laboratories...
The Johnson & Johnson vaccine is different from the Moderna and Pfizer vaccines in a few important ways that could make it a huge help to...
Efforts range from managing a large data center to expanding testing in disadvantaged communities Credit: Erik Jepsen/UC San Diego University of California San Diego was awarded...
Regeneron Pharmaceuticals said an independent panel found the company’s Covid-19 antibody cocktail to have “clear clinical efficacy” in reducing the rates of hospitalization and deaths in...
The spikes on the SARS-CoV-2 virus, which causes COVID-19, change shapes; new research reveals ways that antibodies can recognize these different shapes and block the virus...
The Canadian pharmaceutical market is the 10th largest in the world. What are the biggest pharma stocks on the TSX and TSXV? The post 5 Biggest Canadian...
J&J COVID-19 Jab Is 72% Effective in US trial but more importantly 64% effective against South African Variant
Europe’s drug regulator is evaluating South Korean drugmaker Celltrion’s Covid-19 antibody treatment, the third such drug against the disease to go under real-time review in the...
The U.S. Food and Drug Administration accepted for Priority Review Pfizer Inc.’s Biologics License Application for TicoVac, the company's tick-borne encephalitis vaccine for active immunization to...
Credit: NIAID and Colorado State University WHAT: A randomized, placebo-controlled Phase 1 clinical trial of two monoclonal antibodies (mAbs) directed against the coronavirus that causes Middle...
French researchers are using tiny antibody particles extracted from the family of animals that includes camels and llamas to produce a test they say can detect...
Analysis shows certain racial/ethnic groups and older people aren’t being adequately represented and trial reporting guidelines aren’t being followed Credit: Photo by Robert Hood / Fred...
Pfizer Inc. and BioNTech SE started an international study with 4,000 volunteers to evaluate the safety and effectiveness of their COVID-19 vaccine in healthy pregnant women.
Credit: UPMC PITTSBURGH, Feb. 18, 2021 – A child’s first influenza infection shapes their immunity to future airborne flu viruses–including emerging pandemic strains. But not all...
With the vaccines now being administered at sites around the US, it is important to address misinformation surrounding the effort.
Doctors Endorse Delay Of 2nd Pfizer Jab Even As New Research Shows Low Efficacy Against South African 'Mutant' Following a flurry of data suggesting the first...
A new study shows the South African coronavirus variant may cut the effectiveness of Pfizer/BioNTech’s vaccine by around two thirds
GlaxoSmithKline is expanding a coronavirus antibody collaboration with US biotech Vir, to include potential therapies for flu and The post GSK expands coronavirus antibody tie-up to...
Leaked Video Shows Facebook CEO Questioning "Long-Term Side Effects Of Modifying DNA" In COVID Vaccine Authored by Zachary Stieber via The Epoch Times, Facebook CEO Mark Zuckerberg made comments...
Maintaining antibodies in the blood requires creating certain long-lasting immune cells – but this doesn't always happen.
Vir Biotechnology and GlaxoSmithKline expanded a collaboration to develop strategies against COVID-19 to include work into new treatments for influenza and other respiratory viruses.